2024 MCM | Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC

2024 MCM | Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Luis E. Raez, MD, FACP

Disclosure

Luis E. Raez, MD, FACP discloses no such relationships exist

Accreditation

NA